Photronics, Inc. — Q3 2012 Form 10-Q
Business context and period: Photronics manufactures photomasks used in semiconductor integrated-circuit (IC) and flat-panel-display (FPD) production. This unaudited filing covers the quarter and nine months ended July 29, 2012; comparisons are with the periods ended July 31, 2011. Amounts below are in U.S. dollars, millions, except per-share data.
Financial results
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Net sales | $116.6 | $135.9 | $346.2 | $389.9 |
| Gross margin | 27.7% | 28.1% | 25.3% | 27.0% |
| Operating income | $15.3 | $22.9 | $37.0 | $60.1 |
| Net income attributable to Photronics | $11.0 | $11.3 | $24.0 | $6.9 |
| Diluted EPS | $0.16 | $0.16 | $0.37 | $0.12 |
- Q3 sales declined 14.2%; IC sales fell 13.9% and FPD sales fell 15.1%. Management attributed the decrease primarily to weaker demand amid a semiconductor-industry slowdown. High-end product revenue was $44.7 million, down from $48.5 million.
- Nine-month sales declined 11.2%, primarily reflecting lower mainstream-product demand. High-end product revenue increased to $138.1 million from $120.6 million, supported by IC demand.
- Lower sales weighed on margins in this high-fixed-cost business. Q3 SG&A was nearly flat at $11.8 million, while R&D rose 48% to $5.2 million as advanced-node development activity increased. Nine-month R&D rose 25.5% to $14.1 million.
- Prior-year nine-month earnings included a $35.3 million debt-extinguishment loss; there was no comparable loss in 2012. This materially affects the year-over-year net-income and EPS comparison.
Cash flow, balance sheet and debt
- For the nine months, operating cash flow was $107.5 million, versus $104.5 million. Investing cash outflow was $107.0 million, including $92.0 million of property and equipment purchases and $13.4 million invested in the Micron joint venture. Financing cash inflow was $10.0 million.
- Cash and equivalents were $197.3 million at July 29, 2012, up $7.4 million from October 30, 2011. Working capital was $212.3 million, compared with $209.3 million.
- Total borrowings were $178.5 million, including $7.5 million current, versus $158.2 million at October 30, 2011. Debt includes $115.0 million of 3.25% convertible notes due 2016, $22.1 million of 5.5% convertible notes due 2014, a $24.4 million variable-rate term loan, and capital-lease and customer-financing obligations.
- The company had no revolving-credit borrowings and $30 million available under its revolving facility. The facility is secured by substantially all U.S. assets and certain foreign-subsidiary shares and is subject to financial covenants. The $24.4 million term loan carried a 2.5% rate at quarter-end.
- Capital expenditure commitments were approximately $86 million. The company paid Micron $35 million for the U.S. nanoFab facility and added a $25 million term loan in connection with the purchase.
Outlook, risks and notable items
- No numerical sales or earnings guidance is provided. Management expects much of future revenue growth to come from Asia, with potential North American growth supported by advanced technology available through the Micron technology license.
- Management said resources, including cash and financing capacity, should cover planned capital spending and anticipated working-capital needs for the next 12 months, but cautioned that financing may not be available on favorable terms if needs exceed available resources. Liquidity depends on sales, cash conversion and capital-spending timing.
- The company ceased photomask manufacturing in Singapore. It recorded $1.2 million of restructuring charges through the nine-month period, expects total costs of $1.5–$1.9 million, and expected completion in 2012. Management continues to assess its manufacturing footprint; further closures, asset redeployments, impairments, workforce reductions or added capacity are possible depending on market conditions and customer needs.
- Photomask demand is linked to customer design activity, not necessarily semiconductor or display unit sales. The business is cyclical, seasonal and exposed to utilization, pricing, product mix, technology shifts and competition. Management noted typical short backlogs of one to two weeks for IC masks and two to three weeks for FPD masks.
- A 10% adverse move in the company’s primary foreign currencies was estimated to produce a $2.5 million net unrealized pretax loss. The filing states that a 10% interest-rate change would not have had a material effect for the periods presented.
- The company’s 49.99% Micron joint-venture investment was $93.3 million and represented its stated maximum exposure to loss; additional capital contributions may be requested under the agreement. Ordinary-course claims were not expected to have a material financial-statement effect. No material changes to previously disclosed risk factors were reported.
- PSMC share repurchases raised Photronics’ ownership to 69.40% by quarter-end; a further August repurchase increased it to 71.28%. The repurchases also reduced noncontrolling interests.
Important facts for investors to verify
- Whether demand and utilization stabilize after the reported sales declines, especially in mainstream IC and FPD products.
- Whether margin performance can recover as sales change, given the high fixed-cost base and increased R&D spending.
- How the $86 million of capital commitments, nanoFab investment and debt repayments affect cash and liquidity; monitor credit-facility covenant compliance and financing availability.
- Progress and final cost of the Singapore restructuring, and any further footprint or impairment actions.
- Funding needs and performance of the Micron joint venture, and the implications of changing PSMC ownership and noncontrolling interests.
- Convertible-note dilution and tax exposures: diluted share counts include convertible notes, and unrecognized tax benefits were $3.9 million at quarter-end.